Caption Management’s NeoGenomics NEO Stock Holding History

Caption Management’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-150,000	Closed	-$2.61M	–	1302
2023 Q1	$2.61M	Buy	+150,000	New	+$2.14M	0.05%	383

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Caption Management's NEO Position: Q4 2024 in Review

Caption Management sold out of NeoGenomics (NEO) in Q4 2024, closing a stake of 25,705 shares — an estimated $379K sold.

Caption Management first reported a position in NEO in Q3 2021 and held it in 3 quarters. The position peaked at $379K in Q3 2024. 253 funds tracked by Wall St. Rank hold NEO as of Q4 2024.

Caption Management reported no remaining NeoGenomics position as of Q4 2024 after selling out during the quarter.
Caption Management sold 25,705 NeoGenomics shares in Q4 2024, an estimated $379K.
Caption Management first reported a position in NeoGenomics in Q3 2021 and held it in 3 quarters.
Caption Management's NeoGenomics position peaked at $379K in Q3 2024.
253 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2024.

Based on Caption Management's 13F filing for Q4 2024, filed 14 Feb 2025.